EMEA-002395-PIP01-18
Key facts
Active substance |
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/0333/2018
|
PIP number |
EMEA-002395-PIP01-18
|
Pharmaceutical form(s) |
Capsule, hard
|
Condition(s) / indication(s) |
Treatment of cardiovascular disease
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Les Laboratoires Servier
E-mail: mail.pip.enquiries@servier.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|